Hem › Amyloidos › North Carolina
Kliniska studier för Amyloidos i North Carolina
10 studier för Amyloidos söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Levine Cancer Institute, Charlotte
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Durham
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 23 sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Charlotte
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Chapel Hill
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Charlotte
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Durham
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 8 sep. 2026 · NCT04561518Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Atrium Health Levine Cancer Institute /ID# 255074, Charlotte
- Atrium Health Wake Forest Baptist Medical Center /ID# 255851, Winston-Salem
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 maj 2026 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Duke University Medical Center, Durham
RekryterarFas 3
Ålder 18 till 90 · Alla kön · Uppdaterad 27 mars 2026 · NCT06128629Registry for Adults With Plasma Cell Disorders (PCD's)
- North Carolina Cancer Hospital, Chapel Hill
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 20 nov. 2025 · NCT03717844Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.